Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
84.3 EUR | +1.93% | +6.10% | +40.03% |
Apr. 02 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
Mar. 12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Bullish |
Resistance | 85.00 | 85.00 | 85.00 |
Spread/Res. | -0.82% | -0.82% | -0.82% |
Spread/Supp. | +3.31% | +37.86% | +48.55% |
Support | 81.60 | 61.15 | 56.75 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ROVI Stock
- Charts Laboratorios Farmaceuticos Rovi, S.A.